- Home
- GRAF vs INZY Comparison
GRAF vs INZY Comparison
Compare GRAF & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAF
- INZY
- Stock Information
- Founded
- GRAF 2021
- INZY 2015
- Country
- GRAF United States
- INZY United States
- Employees
- GRAF N/A
- INZY N/A
- Industry
- GRAF
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- GRAF
- INZY Health Care
- Exchange
- GRAF NYSE
- INZY Nasdaq
- Market Cap
- GRAF 294.4M
- INZY 256.3M
- IPO Year
- GRAF 2024
- INZY 2020
- Fundamental
- Price
- GRAF $10.46
- INZY $4.00
- Analyst Decision
- GRAF
- INZY Buy
- Analyst Count
- GRAF 0
- INZY 9
- Target Price
- GRAF N/A
- INZY $15.22
- AVG Volume (30 Days)
- GRAF 4.4K
- INZY 1.0M
- Earning Date
- GRAF 01-01-0001
- INZY 08-05-2025
- Dividend Yield
- GRAF N/A
- INZY N/A
- EPS Growth
- GRAF N/A
- INZY N/A
- EPS
- GRAF 0.32
- INZY N/A
- Revenue
- GRAF N/A
- INZY N/A
- Revenue This Year
- GRAF N/A
- INZY N/A
- Revenue Next Year
- GRAF N/A
- INZY N/A
- P/E Ratio
- GRAF $32.45
- INZY N/A
- Revenue Growth
- GRAF N/A
- INZY N/A
- 52 Week Low
- GRAF $9.03
- INZY $0.72
- 52 Week High
- GRAF $11.02
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- GRAF N/A
- INZY 82.36
- Support Level
- GRAF N/A
- INZY $3.94
- Resistance Level
- GRAF N/A
- INZY $3.97
- Average True Range (ATR)
- GRAF 0.00
- INZY 0.01
- MACD
- GRAF 0.00
- INZY -0.09
- Stochastic Oscillator
- GRAF 0.00
- INZY 66.67
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.